Zentek (CVE:ZEN) Stock Price Up 26.1% – Still a Buy?

Zentek Ltd. (CVE:ZEN) shares rose 26.1% during trading on Thursday . The stock traded as high as C$0.92 and last traded at C$0.87. Approximately 336,524 shares changed hands during mid-day trading, an increase of 408% from the average daily volume of 66,271 shares. The stock had previously closed at C$0.69.

Zentek Stock Up 26.1%

The firm has a market capitalization of C$93.56 million, a P/E ratio of -10.88 and a beta of 0.34. The firm’s 50-day moving average is C$0.76 and its 200 day moving average is C$0.94. The company has a debt-to-equity ratio of 15.41, a quick ratio of 7.59 and a current ratio of 1.00.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.